We are live on ! Find out more
OPTN

OptiNose

Delisted

OPTN was delisted on the 20th of May, 2025.

44 hedge funds and large institutions have $66.9M invested in OptiNose in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $62.2M → $66.9M (+$4.72M)

0.93% more ownership

Funds ownership: 2.61%3.53% (+0.93%)

10% less funds holding

Funds holding: 4944 (-5)

33% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 15

42% less call options, than puts

Call options by funds: $67K | Put options by funds: $116K

43% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 14

Holders
44
Holders Change
-5
Holders Change %
-10.2%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
8
Reduced
14
Closed
15
Calls
$67K
Puts
$116K
Net Calls
-$49K
Net Calls Change
-$48K

OPTN Hedge Fund Activity: Q4 2021 in Review

44 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q4 2021, worth a combined $66.9M — up 7.6% from $62.2M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of OPTN and 10 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 8 added.

The largest buyer was Fidelity Investments, adding an estimated $8.85M. The largest seller was Opaleye Management, exiting entirely with an estimated $4.68M sold.

  • 44 institutional investors held OptiNose (OPTN) as of Q4 2021, down from 49 in Q3 2021.
  • Funds reported $66.9M of OptiNose stock for Q4 2021, up 7.6% quarter-over-quarter.
  • 10 funds opened new OptiNose positions in Q4 2021 and 15 closed out, a net change of -5 holders.
  • The largest OptiNose buyer in Q4 2021 was Fidelity Investments, an estimated $8.85M added.
  • The largest OptiNose seller in Q4 2021 was Opaleye Management, an estimated $4.68M sold.

Based on aggregated 13F filings for Q4 2021.